Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot study.
| Title | Teriparatide (recombinant human parathyroid hormone 1-34) therapy in myeloma patients with severe osteoporosis and fractures despite effective anti-myeloma therapy and bisphosphonates: A pilot study. |
| Publication Type | Journal Article |
| Year of Publication | 2020 |
| Authors | Diamond TH, Golombick T, Manoharan A, Ramakrishna R, Bryant C |
| Journal | Am J Hematol |
| Date Published | 2020 Jun 29 |
| ISSN | 1096-8652 |
| DOI | 10.1002/ajh.25919 |
| Alternate Journal | Am J Hematol |
| PubMed ID | 32602126 |
